AAUM (Average Assets Under Management) of ₹1,321.72 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 60.6% | 59.7% | ▼ -0.9% |
| Healthcare Services | 33.1% | 32.3% | ▼ -0.7% |
| Fertilizers & Agrochemicals | 4.0% | 4.2% | ▲ +0.2% |
| Personal Products | 1.4% | 1.2% | ▼ -0.1% |
| Insurance | 0.4% | 0.0% | ▼ -0.4% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 59.7% | 60.3% | ▲ +0.6% |
| Healthcare Services | 32.3% | 31.9% | ▼ -0.5% |
| Fertilizers & Agrochemicals | 4.2% | 4.9% | ▲ +0.7% |
| Personal Products | 1.2% | 1.2% | ● -0.1% |
| Chemicals & Petrochemicals | 0.0% | 1.0% | ▲ +1.0% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Manipal Health Enterprises Ltd ₹14.96 Cr |
Healthcare Services | 0.97% |
| 2 | BASF India Limited ₹14.90 Cr |
Chemicals & Petrochemicals | 0.97% |
| 3 | SANOFI CONSUMER HEALTHCARE ₹8.47 Cr |
Pharmaceuticals & Biotechnology | 0.55% |
| 4 | Biocon Limited ₹7.98 Cr |
Pharmaceuticals & Biotechnology | 0.52% |
| 5 | Anthem Biosciences Limited ₹11.33 L |
Pharmaceuticals & Biotechnology | 0.01% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹14.82 Cr |
Pharmaceuticals & Biotechnology | 1.02% |
| 2 | IPCA Laboratories Limited ₹8.51 Cr |
Pharmaceuticals & Biotechnology | 0.58% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹98.00 Cr |
Pharmaceuticals & Biotechnology | 5.12% | 6.36% | +1.24% |
| 2 | Abbott India Limited ₹86.82 Cr |
Pharmaceuticals & Biotechnology | 4.97% | 5.63% | +0.66% |
| 3 | Procter & Gamble Health Limited ₹37.25 Cr |
Pharmaceuticals & Biotechnology | 1.79% | 2.42% | +0.63% |
| 4 | Sumitomo Chemical India Limited ₹24.49 Cr |
Fertilizers & Agrochemicals | 0.97% | 1.59% | +0.62% |
| 5 | Pfizer Limited ₹47.12 Cr |
Pharmaceuticals & Biotechnology | 2.50% | 3.06% | +0.56% |
| 6 | GlaxoSmithKline Pharmaceuticals Limited ₹71.87 Cr |
Pharmaceuticals & Biotechnology | 4.12% | 4.66% | +0.54% |
| 7 | Dr. Lal Path Labs Limited ₹33.50 Cr |
Healthcare Services | 1.64% | 2.17% | +0.53% |
| 8 | Rainbow Childrens Medicare Limited ₹75.52 Cr |
Healthcare Services | 4.42% | 4.90% | +0.48% |
| 9 | Sai Life Sciences Limited ₹44.52 Cr |
Pharmaceuticals & Biotechnology | 2.53% | 2.89% | +0.36% |
| 10 | Healthcare Global Enterprises Limited ₹90.21 Cr |
Healthcare Services | 5.52% | 5.85% | +0.33% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹62.78 Cr |
Healthcare Services | 5.68% | 4.07% | -1.61% |
| 2 | Sanofi India Limited ₹3.53 Cr |
Pharmaceuticals & Biotechnology | 1.53% | 0.23% | -1.30% |
| 3 | Mankind Pharma Limited ₹46.53 Cr |
Pharmaceuticals & Biotechnology | 3.85% | 3.02% | -0.83% |
| 4 | Apollo Hospitals Enterprise Limited ₹60.18 Cr |
Healthcare Services | 4.61% | 3.90% | -0.71% |
| 5 | Neuland Laboratories Limited ₹19.30 Cr |
Pharmaceuticals & Biotechnology | 1.60% | 1.25% | -0.35% |
| 6 | Metropolis Healthcare Limited ₹17.32 Cr |
Healthcare Services | 1.45% | 1.12% | -0.33% |
| 7 | Cipla Limited ₹69.81 Cr |
Pharmaceuticals & Biotechnology | 4.77% | 4.53% | -0.24% |
| 8 | Fortis Healthcare Limited ₹48.13 Cr |
Healthcare Services | 3.35% | 3.12% | -0.23% |
| 9 | Global Health Limited ₹32.88 Cr |
Healthcare Services | 2.32% | 2.13% | -0.19% |
| 10 | Lupin Limited ₹40.76 Cr |
Pharmaceuticals & Biotechnology | 2.81% | 2.64% | -0.17% |
37 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹132.40 Cr |
Pharmaceuticals & Biotechnology |
8.59%
|
|
| 2 |
₹98.00 Cr |
Pharmaceuticals & Biotechnology |
6.36%
|
|
| 3 |
₹90.21 Cr |
Healthcare Services |
5.85%
|
|
| 4 |
₹86.82 Cr |
Pharmaceuticals & Biotechnology |
5.63%
|
|
| 5 |
₹75.52 Cr |
Healthcare Services |
4.90%
|
|
| 6 |
₹71.87 Cr |
Pharmaceuticals & Biotechnology |
4.66%
|
|
| 7 |
₹69.81 Cr |
Pharmaceuticals & Biotechnology |
4.53%
|
|
| 8 |
₹65.48 Cr |
Pharmaceuticals & Biotechnology |
4.25%
|
|
| 9 |
₹62.78 Cr |
Healthcare Services |
4.07%
|
|
| 10 |
₹60.18 Cr |
Healthcare Services |
3.90%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.